RVMD Revolution Medicines edges higher after reporting wider than expected Q4 2025 per share loss What the smart money sees in Celularity CELUW that retail does not Bearish Sentiment 20260506 BATRK ATL Braves stock climbs 279 percent despite Q4 2025 EPS miss that fell short of analyst estimates How LightInTheBox LITB maintains its competitive edge